SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1bou'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HSH_C_MK1C402_2
(HIV-II PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
4 / 8 ALA B 175
GLY B 169
ILE B 148
ILE B 106
None
0.69A 1hshD-1bouB:
0.0
1hshD-1bouB:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QW6_A_H4BA901_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
3 / 3 ARG B  91
VAL B  96
TRP B 143
None
0.73A 1qw6A-1bouB:
0.0
1qw6A-1bouB:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1QWC_A_H4BA901_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
3 / 3 ARG B  91
VAL B  96
TRP B 143
None
0.85A 1qwcA-1bouB:
0.0
1qwcA-1bouB:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SDT_B_MK1B902_1
(PROTEASE RETROPEPSIN)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 10 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
0.99A 1sdtA-1bouB:
undetectable
1sdtA-1bouB:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1VAG_A_H4BA901_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
3 / 3 ARG B  91
VAL B  96
TRP B 143
None
0.80A 1vagA-1bouB:
0.0
1vagA-1bouB:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XOT_A_VDNA101_1
(CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 LEU B 110
ILE B 248
MET B 245
PHE B 150
ILE B  75
None
1.35A 1xotA-1bouB:
undetectable
1xotA-1bouB:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z2B_C_VLBC800_2
(TUBULIN ALPHA CHAIN)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
4 / 5 VAL B 152
ASN B  59
VAL B 244
ILE B 248
None
FE  B 501 (-3.2A)
None
None
0.98A 1z2bC-1bouB:
undetectable
1z2bC-1bouB:
19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZGY_A_BRLA503_2
(PEROXISOME
PROLIFERATOR
ACTIVATED RECEPTOR
GAMMA)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
4 / 5 ILE B 214
ILE B 136
MET B 193
LEU B 288
None
0.91A 1zgyA-1bouB:
undetectable
1zgyA-1bouB:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZVI_A_H4BA901_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
3 / 3 ARG B  91
VAL B  96
TRP B 143
None
0.80A 1zviA-1bouB:
0.0
1zviA-1bouB:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AVD_B_SAMB601_1
(CATECHOL-O-METHYLTRA
NSFERASE)
1bou 4,5-DIOXYGENASE
ALPHA CHAIN

(Sphingomonas
paucimobilis)
3 / 3 SER A  43
GLU A  63
ASP A  56
None
0.82A 2avdB-1bouA:
undetectable
2avdB-1bouA:
20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2F8G_B_017B401_2
(POL POLYPROTEIN)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
0.82A 2f8gB-1bouB:
undetectable
2f8gB-1bouB:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HS1_A_017A201_2
(HIV-1 PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 GLY B 274
ALA B 275
ILE B 136
ILE B   8
GLY B 189
None
0.87A 2hs1B-1bouB:
0.0
2hs1B-1bouB:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IGT_A_SAMA1001_0
(SAM DEPENDENT
METHYLTRANSFERASE)
1bou 4,5-DIOXYGENASE
ALPHA CHAIN
4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis;
Sphingomonas
paucimobilis)
5 / 12 PHE A  96
ALA B  15
ALA A 119
GLY B 203
TYR A  79
None
1.03A 2igtA-1bouA:
undetectable
2igtA-1bouA:
18.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2O4K_A_DR7A301_2
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
0.88A 2o4kB-1bouB:
undetectable
2o4kB-1bouB:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2O4L_A_TPVA403_2
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
0.83A 2o4lB-1bouB:
undetectable
2o4lB-1bouB:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q5K_A_AB1A201_2
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
0.75A 2q5kB-1bouB:
undetectable
2q5kB-1bouB:
15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2R5Q_B_1UNB900_1
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 9 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
1.05A 2r5qA-1bouB:
undetectable
2r5qA-1bouB:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2R5Q_B_1UNB900_2
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 11 GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
0.83A 2r5qB-1bouB:
undetectable
2r5qB-1bouB:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2R5Q_D_1UND900_1
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 9 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
1.05A 2r5qC-1bouB:
undetectable
2r5qC-1bouB:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2UXP_B_CLMB1211_0
(HTH-TYPE
TRANSCRIPTIONAL
REGULATOR TTGR)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 11 HIS B 105
ALA B 107
GLY B  76
ILE B 148
VAL B 185
None
1.21A 2uxpB-1bouB:
0.0
2uxpB-1bouB:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VCV_E_ASDE1224_1
(GLUTATHIONE
S-TRANSFERASE A3)
1bou 4,5-DIOXYGENASE
ALPHA CHAIN

(Sphingomonas
paucimobilis)
5 / 9 LEU A  37
LEU A  61
ALA A  73
LEU A  75
PHE A  53
None
1.18A 2vcvE-1bouA:
0.0
2vcvE-1bouA:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VCV_H_ASDH1224_1
(GLUTATHIONE
S-TRANSFERASE A3)
1bou 4,5-DIOXYGENASE
ALPHA CHAIN

(Sphingomonas
paucimobilis)
5 / 9 LEU A  37
LEU A  61
ALA A  73
LEU A  75
PHE A  53
None
1.22A 2vcvH-1bouA:
undetectable
2vcvH-1bouA:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2X2N_D_X2ND1479_1
(LANOSTEROL
14-ALPHA-DEMETHYLASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 ILE B 172
MET B 135
PHE B  34
ALA B  19
ALA B  15
None
1.21A 2x2nD-1bouB:
0.0
2x2nD-1bouB:
20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y00_A_Y00A601_1
(BETA-1 ADRENERGIC
RECEPTOR)
1bou 4,5-DIOXYGENASE
ALPHA CHAIN
4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 LEU B  56
VAL B  57
ASP B 126
SER A  97
PHE A 103
None
1.11A 2y00A-1bouB:
undetectable
2y00A-1bouB:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y00_B_Y00B601_1
(BETA-1 ADRENERGIC
RECEPTOR)
1bou 4,5-DIOXYGENASE
ALPHA CHAIN
4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 LEU B  56
VAL B  57
ASP B 126
SER A  97
PHE A 103
None
1.12A 2y00B-1bouB:
undetectable
2y00B-1bouB:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y01_B_Y00B601_1
(BETA-1 ADRENERGIC
RECEPTOR)
1bou 4,5-DIOXYGENASE
ALPHA CHAIN
4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 LEU B  56
VAL B  57
ASP B 126
SER A  97
PHE A 103
None
1.12A 2y01B-1bouB:
undetectable
2y01B-1bouB:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7H_B_SAMB530_1
(TYPE I RESTRICTION
ENZYME ECOKI M
PROTEIN)
1bou 4,5-DIOXYGENASE
ALPHA CHAIN
4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis;
Sphingomonas
paucimobilis)
3 / 3 TYR A  90
GLU B 242
THR B 271
None
FE  B 501 ( 2.4A)
None
0.88A 2y7hB-1bouA:
undetectable
2y7hB-1bouA:
12.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ADS_B_IMNB3_1
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 GLY B 191
ILE B 214
LEU B 217
LEU B 224
MET B 249
FE  B 501 ( 4.8A)
None
None
None
None
1.31A 3adsB-1bouB:
undetectable
3adsB-1bouB:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BVB_B_017B401_1
(PROTEASE
(RETROPEPSIN))
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
6 / 12 LEU B  16
GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
1.03A 3bvbA-1bouB:
undetectable
3bvbA-1bouB:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3D1Y_A_ROCA201_2
(HIV-1 PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 9 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
1.13A 3d1yB-1bouB:
undetectable
3d1yB-1bouB:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EBZ_B_017B201_1
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 11 LEU B 102
ALA B 175
GLY B 169
ILE B 148
ILE B 106
None
0.93A 3ebzA-1bouB:
0.0
3ebzA-1bouB:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM3_B_478B200_2
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 10 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
0.94A 3em3B-1bouB:
undetectable
3em3B-1bouB:
15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM4_A_DR7A100_1
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 11 GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
0.91A 3em4A-1bouB:
undetectable
3em4A-1bouB:
15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EM6_A_017A200_2
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
0.93A 3em6B-1bouB:
undetectable
3em6B-1bouB:
15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JW2_A_017A401_2
(GAG-POL POLYPROTEIN)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
6 / 12 LEU B  16
GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
1.02A 3jw2B-1bouB:
undetectable
3jw2B-1bouB:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KPB_D_SAMD1000_0
(UNCHARACTERIZED
PROTEIN MJ0100)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 10 ILE B 248
VAL B  57
ILE B  55
ILE B 172
SER B 171
None
1.40A 3kpbD-1bouB:
undetectable
3kpbD-1bouB:
17.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU3_B_478B401_1
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
0.91A 3nu3A-1bouB:
undetectable
3nu3A-1bouB:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU5_B_478B401_1
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
6 / 12 LEU B 133
ILE B 277
GLY B   7
VAL B 187
PRO B  51
ILE B 136
None
1.20A 3nu5A-1bouB:
0.0
3nu5A-1bouB:
14.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXV_B_478B200_2
(HIV-1 PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 10 ILE B 277
GLY B   7
VAL B 187
PRO B  51
ILE B 136
None
1.09A 3oxvB-1bouB:
undetectable
3oxvB-1bouB:
15.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXV_C_478C200_2
(HIV-1 PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 11 ILE B 277
GLY B   7
VAL B 187
PRO B  51
ILE B 136
None
1.07A 3oxvD-1bouB:
undetectable
3oxvD-1bouB:
15.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OXW_B_017B200_2
(HIV-1 PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 10 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
0.96A 3oxwB-1bouB:
undetectable
3oxwB-1bouB:
15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S53_A_017A201_2
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 11 LEU B 102
ALA B 175
GLY B 169
ILE B 148
ILE B 106
None
0.85A 3s53B-1bouB:
undetectable
3s53B-1bouB:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UCB_A_017A201_1
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 LEU B  16
GLY B 274
ILE B 136
GLY B 189
VAL B 131
None
1.00A 3ucbA-1bouB:
undetectable
3ucbA-1bouB:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3V1N_A_BEZA288_0
(2-HYDROXY-6-OXO-6-PH
ENYLHEXA-2,4-DIENOAT
E HYDROLASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 8 GLY B 192
GLY B 191
GLY B 128
LEU B  56
VAL B 131
None
FE  B 501 ( 4.8A)
None
None
None
1.33A 3v1nA-1bouB:
undetectable
3v1nA-1bouB:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4B7Q_C_ZMRC601_2
(NEURAMINIDASE)
1bou 4,5-DIOXYGENASE
ALPHA CHAIN
4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
3 / 3 ARG B 234
ARG A 133
ILE B 230
None
0.85A 4b7qC-1bouB:
undetectable
4b7qC-1bouB:
19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DQB_B_017B101_1
(ASPARTYL PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
0.94A 4dqbA-1bouB:
undetectable
4dqbA-1bouB:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JLG_A_SAMA401_0
(HISTONE-LYSINE
N-METHYLTRANSFERASE
SETD7)
1bou 4,5-DIOXYGENASE
ALPHA CHAIN
4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis;
Sphingomonas
paucimobilis)
5 / 12 ALA A 107
GLY A 108
GLY A 126
HIS B 195
GLU B 239
None
1.15A 4jlgA-1bouA:
undetectable
4jlgA-1bouA:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJT_B_017B101_1
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 11 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
0.96A 4njtA-1bouB:
undetectable
4njtA-1bouB:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_A_1LDA501_0
(CYTOSINE DEAMINASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 HIS B  61
HIS B  12
GLU B  86
ASP B 126
SER B  63
FE  B 501 ( 3.3A)
FE  B 501 ( 3.3A)
None
None
None
1.41A 4r88A-1bouB:
undetectable
4r88A-1bouB:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_B_1LDB501_0
(CYTOSINE DEAMINASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 HIS B  61
HIS B  12
GLU B  86
ASP B 126
SER B  63
FE  B 501 ( 3.3A)
FE  B 501 ( 3.3A)
None
None
None
1.39A 4r88B-1bouB:
undetectable
4r88B-1bouB:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_C_1LDC501_0
(CYTOSINE DEAMINASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 HIS B  61
HIS B  12
GLU B  86
ASP B 126
SER B  63
FE  B 501 ( 3.3A)
FE  B 501 ( 3.3A)
None
None
None
1.42A 4r88C-1bouB:
undetectable
4r88C-1bouB:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_D_1LDD501_0
(CYTOSINE DEAMINASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 HIS B  61
HIS B  12
GLU B  86
ASP B 126
SER B  63
FE  B 501 ( 3.3A)
FE  B 501 ( 3.3A)
None
None
None
1.43A 4r88D-1bouB:
undetectable
4r88D-1bouB:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_E_1LDE501_0
(CYTOSINE DEAMINASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 HIS B  61
HIS B  12
GLU B  86
ASP B 126
SER B  63
FE  B 501 ( 3.3A)
FE  B 501 ( 3.3A)
None
None
None
1.39A 4r88E-1bouB:
undetectable
4r88E-1bouB:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_F_1LDF502_0
(CYTOSINE DEAMINASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 HIS B  61
HIS B  12
GLU B  86
ASP B 126
SER B  63
FE  B 501 ( 3.3A)
FE  B 501 ( 3.3A)
None
None
None
1.43A 4r88F-1bouB:
undetectable
4r88F-1bouB:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4YSH_B_GLYB401_0
(GLYCINE OXIDASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
4 / 6 PHE B  81
LYS B  97
GLY B  98
ALA B 103
None
1.30A 4yshB-1bouB:
0.0
4yshB-1bouB:
22.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DPD_B_SAMB601_0
(PROTEIN LYSINE
METHYLTRANSFERASE 1)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 GLY B 162
LEU B 168
VAL B 244
TRP B 246
VAL B 152
None
1.08A 5dpdB-1bouB:
undetectable
5dpdB-1bouB:
19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E5J_A_017A201_1
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 LEU B 102
ALA B 175
GLY B 169
ILE B 148
ILE B 106
None
0.81A 5e5jA-1bouB:
undetectable
5e5jA-1bouB:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E5J_A_017A201_2
(PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 LEU B 102
ALA B 175
GLY B 169
ILE B 148
ILE B 106
None
0.88A 5e5jB-1bouB:
undetectable
5e5jB-1bouB:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E5K_B_017B201_2
(HIV-1 PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 LEU B 102
ALA B 175
GLY B 169
ILE B 148
ILE B 106
None
0.81A 5e5kB-1bouB:
undetectable
5e5kB-1bouB:
14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FVO_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
3 / 3 ARG B  91
VAL B  96
TRP B 143
None
0.90A 5fvoA-1bouB:
0.0
5fvoA-1bouB:
20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IKT_B_TLFB601_1
(PROSTAGLANDIN G/H
SYNTHASE 2)
1bou 4,5-DIOXYGENASE
ALPHA CHAIN
4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis;
Sphingomonas
paucimobilis)
3 / 3 TYR A 118
TYR B 264
SER B 194
None
1.00A 5iktB-1bouA:
undetectable
5iktB-1bouA:
14.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JQB_B_IBPB706_1
(ENVELOPE
GLYCOPROTEIN
1,ENVELOPE
GLYCOPROTEIN
1,ENVELOPE
GLYCOPROTEIN 1
ENVELOPE
GLYCOPROTEIN 2)
1bou 4,5-DIOXYGENASE
ALPHA CHAIN

(Sphingomonas
paucimobilis)
5 / 8 ARG A  77
LEU A  92
LEU A  95
LEU A  66
LEU A  37
None
1.41A 5jqbA-1bouA:
undetectable
5jqbB-1bouA:
undetectable
5jqbA-1bouA:
18.18
5jqbB-1bouA:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KQX_A_ROCA101_2
(PROTEASE E35D-SQV)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 9 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
1.05A 5kqxB-1bouB:
undetectable
5kqxB-1bouB:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KR0_A_478A101_2
(PROTEASE E35D-APV)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 9 LEU B  16
GLY B 274
ALA B 275
GLY B 189
VAL B 131
None
1.02A 5kr0B-1bouB:
undetectable
5kr0B-1bouB:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KR2_C_ROCC101_2
(PROTEASE PR5-SQV)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 9 LEU B 133
ILE B 277
GLY B   7
PRO B  51
ILE B 136
None
1.00A 5kr2D-1bouB:
undetectable
5kr2D-1bouB:
13.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XIO_A_HFGA801_0
(PROLINE-TRNA
SYNTHETASE CLASS II
AARS (YBAK RNA
BINDING DOMAIN PLUS
TRNA SYNTHETASE))
1bou 4,5-DIOXYGENASE
ALPHA CHAIN
4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis;
Sphingomonas
paucimobilis)
5 / 12 VAL B 155
GLU B  86
PHE A  96
THR A  98
GLY B  87
None
1.33A 5xioA-1bouB:
undetectable
5xioA-1bouB:
20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CDU_A_EY4A501_0
(CHIMERIC ALPHA1GABAA
RECEPTOR)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
4 / 5 VAL B 187
TRP B 188
PRO B  51
THR B 190
None
1.34A 6cduA-1bouB:
0.0
6cduB-1bouB:
undetectable
6cduA-1bouB:
21.15
6cduB-1bouB:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CDU_I_EY4I500_0
(CHIMERIC ALPHA1GABAA
RECEPTOR)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
4 / 5 VAL B 187
TRP B 188
PRO B  51
THR B 190
None
1.22A 6cduI-1bouB:
0.0
6cduJ-1bouB:
0.0
6cduI-1bouB:
21.15
6cduJ-1bouB:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
0.83A 6difB-1bouB:
undetectable
6difB-1bouB:
14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
0.83A 6dj1B-1bouB:
undetectable
6dj1B-1bouB:
14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 GLY B 274
ALA B 275
ILE B   8
GLY B 189
VAL B 131
None
0.85A 6dj2B-1bouB:
undetectable
6dj2B-1bouB:
14.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DWN_D_AQ4D602_0
(CYTOCHROME P450 1A1)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
5 / 12 ILE B 106
PHE B 115
GLY B 169
ALA B 252
ASP B 170
None
1.11A 6dwnD-1bouB:
0.0
6dwnD-1bouB:
14.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MN4_E_AM2E301_0
(AMINOGLYCOSIDE
N(3)-ACETYLTRANSFERA
SE, AAC(3)-IVA)
1bou 4,5-DIOXYGENASE BETA
CHAIN

(Sphingomonas
paucimobilis)
4 / 7 TRP B  43
THR B   6
ARG B 291
ASP B 259
None
1.30A 6mn4E-1bouB:
0.0
6mn4E-1bouB:
21.04